During the last session, Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares were 0.37 million, with the beta value of the company hitting -2.90. At the
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting -3.41. At the close
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares stood at 0.78 million during the last session, with the company’s beta value hitting -3.39. At the close
In last trading session, Structure Therapeutics Inc ADR (NASDAQ:GPCR) saw 3.4 million shares changing hands with its beta currently measuring -3.47. Company’s recent per share
Structure Therapeutics Inc ADR (NASDAQ:GPCR) has a beta value of -3.47 and has seen 1.35 million shares traded in the recent trading session. The company,
During the last session, Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares were 0.5 million, with the beta value of the company hitting -3.48. At the
In the last trading session, 1.73 million shares of the Structure Therapeutics Inc ADR (NASDAQ:GPCR) were traded, and its beta was -3.55. Most recently the
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares stood at 0.88 million during the last session, with the company’s beta value hitting -3.51. At the close
Structure Therapeutics Inc ADR (NASDAQ:GPCR) has a beta value of -3.64 and has seen 1.21 million shares traded in the last trading session. The company,
In the last trading session, 2.09 million shares of the Structure Therapeutics Inc ADR (NASDAQ:GPCR) were traded, and its beta was -3.48. Most recently the
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
